Evidence map›Paper›PMID 33799534›Full record

ArticleFoods (Basel, Switzerland)2021

Anti-Apoptotic and Anti-Inflammatory Role of Trans ε-Viniferin in a Neuron-Glia Co-Culture Cellular Model of Parkinson's Disease.

Domenico Sergi, Alex Gélinas, Jimmy Beaulieu, Justine Renaud, Emilie Tardif-Pellerin, Jérôme Guillard, Maria-Grazia Martinoli

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Domenico SergiCellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, QC G9A 5H7, Canada.
Alex GélinasCellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, QC G9A 5H7, Canada.
Jimmy BeaulieuCellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, QC G9A 5H7, Canada.
Justine RenaudCellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, QC G9A 5H7, Canada.
Emilie Tardif-PellerinCellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, QC G9A 5H7, Canada.
Jérôme GuillardUMR CNRS 7285 IC2MP, Equipe 5 Synthese Organique, UFR Médecine et Pharmacie, Université de Poitiers, 86073 Poitiers CEDEX 9, France.
Maria-Grazia MartinoliCellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, QC G9A 5H7, Canada.
Université du Québec à Trois-Rivières · CAInstitut de Chimie des Milieux et des Matériaux de Poitiers · FRUniversité Laval · CAUniversity of Adelaide · AU

Funding

Natural Sciences and Engineering Research Council of Canada 04321
6 · The paper itself

Abstract

The polyphenol trans-ε-viniferin (viniferin) is a dimer of resveratrol, reported to hold antioxidant and anti-inflammatory properties. The aims of our study were to evaluate the neuroprotective potential of viniferin in the nerve growth factor (NGF)-differentiated PC12 cells, a dopaminergic cellular model of Parkinson's disease (PD) and assess its anti-inflammatory properties in a N9 microglia-neuronal PC12 cell co-culture system. The neuronal cells were pre-treated with viniferin, resveratrol or their mixture before the administration of 6-hydroxydopamine (6-OHDA), recognized to induce parkinsonism in rats. Furthermore, N9 microglia cells, in a co-culture system with neuronal PC12, were pre-treated with viniferin, resveratrol or their mixture to investigate whether these polyphenols could reduce lipopolysaccharide (LPS)-induced inflammation. Our results show that viniferin as well as a mixture of viniferin and resveratrol protects neuronal dopaminergic cells from 6-OHDA-induced cytotoxicity and apoptosis. Furthermore, when viniferin, resveratrol or their mixture was used to pre-treat microglia cells in our co-culture system, they reduced neuronal cytotoxicity induced by glial activation. Altogether, our data highlight a novel role for viniferin as a neuroprotective and anti-inflammatory molecule in a dopaminergic cellular model, paving the way for nutraceutical therapeutic avenues in the complementary treatments of PD.

Indexed as

apotosisdopamineneuroinflammationneuroprotectionoxidative stressParkinson’s diseaseresveratroltrans-ε-viniferin

Identifiers

PMID33799534
PMCPMC7998636
OpenAlexW3134501590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.